Colorado’s Drug Price Cap Blocked | Denver News

Colorado’s bold move to cap the price of arthritis drug Enbrel has hit a major legal roadblock, as a federal judge blocked the state’s effort, citing federal patent law that prohibits states from directly setting prices on patented drugs. The ruling, issued last week, also casts doubt on Colorado’s broader drug affordability strategy, which flagged other pricey treatments as unaffordable — while deeming drugs like Trikafta and Genvoya affordable thanks to patient assistance programs. Consumer advocates see the decision as a setback for patients, while pharma companies argue states should target insurers and PBMs instead. Colorado may appeal, but for now, the state’s plan faces a significant legal hurdle — and the battle over drug pricing continues. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/999da2bc98dd64aa